Read More Analyst Ratings News Price Target Upgrades TD Securities Upgrades Range Resources to Buy, Raises Price Target to $33 By Benzinga Newsdesk September 29, 9:34 AM TD Securities analyst Aaron Bilkoski upgrades Range Resources (NYSE:RRC) from Hold to Buy and raises the price target from $32 to $33. RRC
Read More General News Politics Rumors Senate Majority Leader Chuck Schumer Says ‘We’re Getting There’ On Debit Limit Deal By Benzinga Newsdesk October 7, 10:02 AM -Bloomberg SPY
Read More News ‘Unsupervised Self-Driving Will Debut In New Volvo Electric SUV’ -InsideEVs By Benzinga Newsdesk January 10, 12:39 PM https://insideevs.com/news/559817/volvo-ride-pilot-unsupervised-2023/ TSLA
Read More Analyst Color Analyst Ratings Biotech General Health Care Movers News Price Target Trading Ideas BMO Capital Says Risk/Reward For This Gene Stock Assumes Clinical Success By Vandana Singh June 17, 2:28 PM BMO Capital initiated coverage on Beam Therapeutics Inc (NASDAQ:BEAM) with a Market Perform rating and a price target of 41. BMO writes… BEAM